Anaphylactic reactions during anaesthesia - Let us treat the problem rather than debating its existence

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 4, 2005, Pages 431-433

  Mertes, P M ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; QUATERNARY AMMONIUM DERIVATIVE;

ANAPHYLAXIS; ANESTHESIA COMPLICATION; EDITORIAL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INCIDENCE; INTERNATIONAL COOPERATION; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANAPHYLAXIS; ANESTHESIA; ANESTHETICS; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; NEUROMUSCULAR BLOCKING AGENTS; QUATERNARY AMMONIUM COMPOUNDS;

EID: 16844377485     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2005.00682.x     Document Type: Editorial

References (26)

1. Currie M, Webb RK, Williamson JA, Russell WJ, Mackay P. The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 1993; 21 (5): 621-5.
2. Mitsuhata H, Matsumoto S, Hasegawa J. The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui 1992; 41: 1664-9.
3. Axon AD, Hunter JM. Editorial III. Anaphylaxis and anaesthesia - all clear now? Br J Anaesth 2004; 93 (4): 501-4.
4. Whittington T, Fisher MM. Anaphylactic and anaphylactoid reactions. Clinical Anaesthesiology. B Clin Anaesthesiol 1998; 12: 301-23.
5. Laxenaire MC. Epidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996 Ann Fr Anesth Reanim 1999; 18: 796-809.
6. Garvey LH, Roed-Petersen J, Menne T, Husum B. Danish Anaesthesia Allergy Centre - preliminary results. Acta Anaesthesiol Scand 2001; 45 (10): 1204-9.
7. Fisher MM, More DG. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 1981; 9 (3): 226-34.
8. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12 (2): 97-104.
9. Watkins J. Adverse reaction to neuromuscular blockers, frequency, investigation, and epidemiology. Acta Anaesthesiol Scand Suppl 1994; 102: 6-10.
10. Laxenaire M, Mertes PM. GERAP: Anaphylaxis during anaesthesia. Results of a 2 year survey in France. Br J Anaesth 2001; 21 (1): 549-58.
11. Guttormsen AB. Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001; 45 (10): 1189-90.
12. Escolano F, Valero A, Huguet J et al. [Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7)]. Rev Esp Anestesiol Reanim 2002; 49 (6): 286-93.
13. Soetens FM, Smolders FJ, Meeuwis HC et al. Intradermal skin testing in the investigation of suspected anaphylactic reactions during anaesthesia - a retrospective survey. Acta Anaesthesiol Belg 2003; 54 (1): 59-63.
14. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99 (3): 536-45.
15. Florvaag E, Johansson S, Öman H et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005; 49: 445-52.
16. Gueant JL, Mata E, Monin B et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 1991; 46 (6): 452-8.
17. Guilloux L, Ricard-Blum S, Ville G, Motin J. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 1992; 90 (2): 153-9.
18. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs, the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 2000; 28: 167-70.
19. Porri F, Lemiere C, Birnbaum J et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 1999; 29 (1): 72-5.
20. Mertes PM, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002; 19: 240-62.
21. Mertes PM, Laxenaire MC. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep 2004; 4 (1): 7-16.
22. Mertes PM, Laxenaire MC. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol 2004; 70 (5): 285-91.
23. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983; 306 (5940): 262-4.
24. Mertes PM, Laxenaire M. Anaphylaxis during general anaesthesia. Prevention and management. CNS Drugs 2000; 14 (2): 115-33.
25. Fisher MM, Doig GS. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf 2004; 27 (6): 393-410.
26. Reducing the risk of anaphylaxis during anaesthesia. Abbreviated text. Ann Fr Anesth Reanim 2002; 21 (Suppl. 1): 7s-23s.